Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Jurgis Bekepuris who wrote (39671)	10/14/2010 1:02:18 PM
From: Jurgis Bekepuris	Read Replies (2) \| Respond to of 78655

Looking at APOL results: finance.yahoo.com Q4 is not that bad, the big bite is a goodwill writeoff. However, if enrollment drops 40%+ and earnings drop accordingly, the company is not really undervalued. Considering earning run rate at about 300M per year the straightforward PE is about 17. If the company can grow at 20% from the drop to 300M, then it's a buy, if it only grows at about 15% from there, then it's not. :) 300M might be conservative, however, I don't account for any lawsuits, fixed overhead, additional regulations, loan losses, etc. So it might be also very optimistic... Anyone has other thoughts? Or should we declare this all to be asbestos and move on? ;)